These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36902065)

  • 1. Electrical Remodeling in Right Ventricular Failure Due to Pulmonary Hypertension: Unraveling Novel Therapeutic Targets.
    Park JF; Liang J; Umar S
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure.
    Park JF; Clark VR; Banerjee S; Hong J; Razee A; Williams T; Fishbein G; Saddic L; Umar S
    Circ Heart Fail; 2021 Feb; 14(2):e007058. PubMed ID: 33541093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.
    Al-Qazazi R; Lima PDA; Prisco SZ; Potus F; Dasgupta A; Chen KH; Tian L; Bentley RET; Mewburn J; Martin AY; Wu D; Jones O; Maurice DH; Bonnet S; Provencher S; Prins KW; Archer SL
    Am J Respir Crit Care Med; 2022 Sep; 206(5):608-624. PubMed ID: 35699679
    [No Abstract]   [Full Text] [Related]  

  • 4. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
    Akazawa Y; Okumura K; Ishii R; Slorach C; Hui W; Ide H; Honjo O; Sun M; Kabir G; Connelly K; Friedberg MK
    J Appl Physiol (1985); 2020 Aug; 129(2):238-246. PubMed ID: 32644912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.
    Xie YP; Chen B; Sanders P; Guo A; Li Y; Zimmerman K; Wang LC; Weiss RM; Grumbach IM; Anderson ME; Song LS
    Hypertension; 2012 Feb; 59(2):355-62. PubMed ID: 22203744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
    Suen CM; Chaudhary KR; Deng Y; Jiang B; Stewart DJ
    Cardiovasc Res; 2019 Mar; 115(4):788-799. PubMed ID: 30357319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta1-adrenoceptor antagonist, metoprolol attenuates cardiac myocyte Ca
    Fowler ED; Drinkhill MJ; Norman R; Pervolaraki E; Stones R; Steer E; Benoist D; Steele DS; Calaghan SC; White E
    J Mol Cell Cardiol; 2018 Jul; 120():74-83. PubMed ID: 29807024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
    Omura J; Habbout K; Shimauchi T; Wu WH; Breuils-Bonnet S; Tremblay E; Martineau S; Nadeau V; Gagnon K; Mazoyer F; Perron J; Potus F; Lin JH; Zafar H; Kiely DG; Lawrie A; Archer SL; Paulin R; Provencher S; Boucherat O; Bonnet S
    Circulation; 2020 Oct; 142(15):1464-1484. PubMed ID: 32698630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural Changes of the Right Ventricular Myocytes in Pulmonary Arterial Hypertension.
    Shults NV; Kanovka SS; Ten Eyck JE; Rybka V; Suzuki YJ
    J Am Heart Assoc; 2019 Mar; 8(5):e011227. PubMed ID: 30807241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
    Kang Y; Zhang G; Huang EC; Huang J; Cai J; Cai L; Wang S; Keller BB
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H853-H866. PubMed ID: 32108526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
    Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling.
    Wu J; Liu T; Shi S; Fan Z; Hiram R; Xiong F; Cui B; Su X; Chang R; Zhang W; Yan M; Tang Y; Huang H; Wu G; Huang C
    Cardiovasc Diabetol; 2022 Sep; 21(1):197. PubMed ID: 36171554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Endothelin-1 in Right Atrial Arrhythmogenesis in Rabbits with Monocrotaline-Induced Pulmonary Arterial Hypertension.
    Lu YY; Lin FJ; Chen YC; Kao YH; Higa S; Chen SA; Chen YJ
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of estrogen on right ventricular remodeling of monocrotaline-induced pulmonary arterial hypertension in rats and its mechanism.
    Liu Z; Duan YL; Ge SL; Zhang CX; Gong WH; Xu JJ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1742-1750. PubMed ID: 30840299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursolic Acid Improves Monocrotaline-Induced Right Ventricular Remodeling by Regulating Metabolism.
    Gao X; Zhang Z; Li X; Wei Q; Li H; Li C; Chen H; Liu C; He K
    J Cardiovasc Pharmacol; 2020 Jun; 75(6):545-555. PubMed ID: 32141989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
    Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F
    Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension.
    Potus F; Ruffenach G; Dahou A; Thebault C; Breuils-Bonnet S; Tremblay È; Nadeau V; Paradis R; Graydon C; Wong R; Johnson I; Paulin R; Lajoie AC; Perron J; Charbonneau E; Joubert P; Pibarot P; Michelakis ED; Provencher S; Bonnet S
    Circulation; 2015 Sep; 132(10):932-43. PubMed ID: 26162916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension.
    Strauss B; Sassi Y; Bueno-Beti C; Ilkan Z; Raad N; Cacheux M; Bisserier M; Turnbull IC; Kohlbrenner E; Hajjar RJ; Hadri L; Akar FG
    J Mol Cell Cardiol; 2019 Feb; 127():20-30. PubMed ID: 30502350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
    Sun XQ; Peters EL; Schalij I; Axelsen JB; Andersen S; Kurakula K; Gomez-Puerto MC; Szulcek R; Pan X; da Silva Goncalves Bos D; Schiepers REJ; Andersen A; Goumans MJ; Vonk Noordegraaf A; van der Laarse WJ; de Man FS; Bogaard HJ
    Am J Respir Cell Mol Biol; 2021 Mar; 64(3):331-343. PubMed ID: 33264068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.